20/20 Biolabs earnings were N/A for the trailing 12 months ending Mar 31, 2026, with N/A growth year over year. The latest AIDX earnings report on Mar 31, 2026 announced Q1 2026 earnings of -$2.1M, up 62.2% from last quarter. For the last reported fiscal year 2025 ending Dec 31, 2025, AIDX reported annual earnings of -$3.7M, with -32.7% growth.
AIDX earnings history
Current Revenue
$0.0
Current Earnings
$0.0
Current Profit Margin
0%
AIDX Return on Equity
Insufficient data to display
AIDX Return on Assets
Insufficient data to display
Be the first to know when AIDX announces earnings.
20/20 Biolabs (NASDAQ: AIDX) reported Q1 2026 earnings per share (EPS) of -$0.28, up 75% year over year. Total AIDX earnings for the quarter were -$2.12 million. In the same quarter last year, 20/20 Biolabs's earnings per share (EPS) was -$0.16.
As of the last 20/20 Biolabs earnings report, 20/20 Biolabs is currently losing money. 20/20 Biolabs's net profit (also called net income) for the twelve months ending Mar 31, 2026 was N/A, a N/A decrease year over year.
What was AIDX's earnings growth in the past year?
As of 20/20 Biolabs's earnings date in Q2 2026, 20/20 Biolabs's earnings has grown year over year. AIDX earnings in the past year totalled N/A.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.